Sign in

Private company

RGenix (United States)

RGenix (United States) is an American biotechnology company that raised $55.1 million in 2022 (SEC Form D).1 It is headquartered in Brooklyn.1

Last updated Oct 21, 2026.

Overview

  • HeadquartersBrooklyn1
  • Websiteinspirna.com
  • Incorporated inDE3
  • Business address310 East 67Th Street, Suite 1-12, New York, Ny 100653
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerDavid Darst named Aug 29, 20224
  • Executive Officer, DirectorMasoud Tavazoie named Aug 29, 20224
  • DirectorAntoine Papiernik named Aug 29, 20224
  • DirectorDieter Weinand named Aug 29, 20224
  • DirectorEric Rowinsky named Aug 29, 20224
  • DirectorJack Nielsen named Aug 29, 20224
  • DirectorJue Pu named Aug 29, 20224
  • DirectorMichael Ginder named Aug 29, 20224
  • DirectorPeter Van Vlasselaer named Aug 29, 20224
  • DirectorRaymond Camahort named Aug 29, 20224

Former names

  • Rgenix, Inc.Aug 18, 2015 to Feb 24, 20213

Filings

2 filings to the SEC since October 2021: 2 private raises. The latest 2:

  1. Aug 29, 2022D/A EDGAR
  2. Jul 11, 2022D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$55.1M 2022–2022
Money received by yearMoney received by year, 2022–2022: $55.1M in all. Private raises (Form D) $55.1M.$0$20M$40M$60M2022 · Private raises (Form D): $55.1M2022
Figures by year
YearPrivate raises (Form D)Total
2022$55.1M$55.1M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Jun 24, 2022Raised $55.1 million in a private offering of equity4 Form D: 20 investors so far Form D

SEC filer profile

How RGenix (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARInspirna, Inc.2
  • CIK0001651159
  • Employer ID (EIN)27-31204092
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Business address310 East 67Th Street, Suite 1-12, New York, NY 100652
  • Phone646.856.92612
  • On EDGAR sinceAug 18, 20152
  • Filings6 in all: D (5), D/A (1)2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4